Factorial Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,000
Closed -$1.08M 89
2023
Q2
$1.08M Buy
+14,000
New +$1.12M 0.74% 54
2022
Q4
Sell
-21,300
Closed -$1.31M 92
2022
Q3
$1.31M Buy
21,300
+3,000
+16% +$189K 1.14% 33
2022
Q2
$1.13M Buy
18,300
+1,600
+10% +$99.1K 0.92% 44
2022
Q1
$993K Buy
16,700
+2,900
+21% +$185K 0.68% 57
2021
Q4
$1M Sell
13,800
-13,000
-49% -$895K 0.66% 50
2021
Q3
$1.87M Sell
26,800
-5,000
-16% -$351K 1.27% 28
2021
Q2
$2.19M Buy
31,800
+3,300
+12% +$220K 1.48% 26
2021
Q1
$1.84M Sell
28,500
-6,500
-19% -$419K 1.29% 26
2020
Q4
$2.04M Buy
35,000
+18,600
+113% +$1.12M 1.7% 17
2020
Q3
$1.04M Sell
16,400
-100
-0.6% -$6.93K 1.06% 29
2020
Q2
$1.27M Sell
16,500
-22,500
-58% -$1.72M 1.39% 26
2020
Q1
$2.92M Sell
39,000
-46,400
-54% -$3.21M 3.89% 4
2019
Q4
$5.48M Buy
85,400
+43,800
+105% +$2.85M 2.51% 12
2019
Q3
$2.64M Buy
41,600
+500
+1% +$32.7K 2.53% 11
2019
Q2
$2.78M Buy
41,100
+6,200
+18% +$408K 2.66% 7
2019
Q1
$2.27M Buy
34,900
+14,600
+72% +$970K 2.14% 10
2018
Q4
$1.27M Buy
20,300
+500
+3% +$34.9K 1.33% 22
2018
Q3
$1.53M Sell
19,800
-2,800
-12% -$211K 1.31% 26
2018
Q2
$1.6M Buy
22,600
+15,200
+205% +$1.07M 1.43% 24
2018
Q1
$558K Sell
7,400
-24,100
-77% -$1.92M 0.51% 70
2017
Q4
$2.26M Buy
+31,500
New +$2.39M 2.09% 12

Other funds holding GILD

Factorial Partners's GILD Position: Q3 2023 in Review

Factorial Partners sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 14,000 shares — an estimated $1.08M sold.

Factorial Partners first reported a position in GILD in Q4 2017 and held it in 21 quarters. The position peaked at $5.48M in Q4 2019. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Factorial Partners reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Factorial Partners sold 14,000 Gilead Sciences shares in Q3 2023, an estimated $1.08M.
  • Factorial Partners first reported a position in Gilead Sciences in Q4 2017 and held it in 21 quarters.
  • Factorial Partners's Gilead Sciences position peaked at $5.48M in Q4 2019.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Factorial Partners's 13F filing for Q3 2023, filed 13 Nov 2023.